These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Basic principles of clinical evaluation of medications]. Cichutek K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):395-6. PubMed ID: 15830248 [No Abstract] [Full Text] [Related]
3. [The safety and registration of pharmaceuticals from the point of view of the medical practitioner]. Kaiser RH Radiologe; 2002 Dec; 42(12):1016-24; quiz 1024-5. PubMed ID: 12602329 [No Abstract] [Full Text] [Related]
4. Inquiry says that "UK drugs policy is failing". Burki T Lancet; 2019 Nov; 394(10209):1605. PubMed ID: 31690436 [No Abstract] [Full Text] [Related]
5. An Open Letter to Health Canada. Papp K; Albrecht L; Barber K; Bourcier M; Dion PL; Freiman A; Gooderham M; Guenther L; Gulliver W; Hong CH; Lynde C; Poulin Y; Siddha S; Toole J; Toth D; Vender R; Wasel N; Wiseman M J Cutan Med Surg; 2017; 21(3):195-196. PubMed ID: 28903599 [No Abstract] [Full Text] [Related]
6. European Medicines Agency assesses safety reporting at Roche. Marshall H Lancet Oncol; 2012 Aug; 13(8):e331. PubMed ID: 23024993 [No Abstract] [Full Text] [Related]
7. Law, medicines and the doctor: a critical look at drug regulation. Dukes MN Curr Med Res Opin; 1973; 1(10):612-28. PubMed ID: 4778727 [No Abstract] [Full Text] [Related]
8. Regulatory advice on evaluation of the proarrhythmic potential of drugs. Stockbridge N; Throckmorton DC J Electrocardiol; 2004; 37 Suppl():40-1. PubMed ID: 15534791 [No Abstract] [Full Text] [Related]
9. Health (drugs and poisons) regulation 1996. The implications for nurses. Qld Nurse; 1997; 16(1):24-5. PubMed ID: 9282073 [No Abstract] [Full Text] [Related]
10. Counterfeit drugs pose growing health threat. Traynor K Am J Health Syst Pharm; 2010 Nov; 67(22):1896, 1898. PubMed ID: 21048204 [No Abstract] [Full Text] [Related]
11. Drugs policy will not change as long as UK government refuses to acknowledge the need for change. Robertson R; McAuley A; Macleod J; Strang J; McCallum A BMJ; 2018 Jun; 361():k2604. PubMed ID: 29925647 [No Abstract] [Full Text] [Related]
12. [Legal medicine aspects of current abuse potential]. Kauert G; Eisenmenger W Versicherungsmedizin; 1993 Feb; 45(1):15-7. PubMed ID: 8438535 [TBL] [Abstract][Full Text] [Related]
13. The new Health (Drugs and Poisons) Regulation. Qld Nurse; 1996; 15(5):19. PubMed ID: 9416183 [No Abstract] [Full Text] [Related]
14. Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad. Croft DE; Wykoff CC; Michels S; Chakravarthy U; Cruess AF Am J Ophthalmol; 2016 Sep; 169():xiv-xvi. PubMed ID: 27485923 [No Abstract] [Full Text] [Related]
15. The medical ethics of clinical therapeutic trials. de Wet BS S Afr Med J; 1973 Jan; 47(1):18-21. PubMed ID: 4686243 [No Abstract] [Full Text] [Related]
16. Drugs: their uses and abuses, and the problem of their control. Dunlop D Vet Rec; 1969 Oct; 85(16):424-9. PubMed ID: 5387898 [No Abstract] [Full Text] [Related]
17. Health (drugs and poisons) regulations 1996. Qld Nurse; 1997; 16(2):19-20. PubMed ID: 9305147 [No Abstract] [Full Text] [Related]
18. Present attitudes of governmental drug regulatory agencies. Noel PR Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283 [No Abstract] [Full Text] [Related]